Methylation of CpG islands: Potential relevance for hypertension and kidney diseases

Nephrology Dialysis Transplantation

Volumn 20, Issue 5, 2005, Pages 868-869

  Frey, Felix J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CORTICOSTERONE; CYTOSINE; DNA METHYLTRANSFERASE; ENDOTHELIN CONVERTING ENZYME; HYDROCORTISONE; METHYL CPG BINDING PROTEIN; PROCAINAMIDE;

BLOOD PRESSURE REGULATION; CANCER INHIBITION; CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; DNA SYNTHESIS INHIBITION; EDITORIAL; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENOME IMPRINTING; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CPG ISLANDS; DNA METHYLATION; GENE SILENCING; HUMANS; HYPERTENSION; KIDNEY DISEASES;

EID: 18944407842     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh746     Document Type: Editorial

References (19)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428
2. Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics 1992; 13: 1095-1107
3. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196: 261-282
4. Taddei A, Maison C, Roche D, Almouzni G. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol 2001; 3: 114-120
5. Razin A, Shemer R. DNA methylation in early development. Hum Mol Genet 1995; 4 Special issue: 1751-1755
6. Rand E, Cedar H. Regulation of imprinting: a multi-tiered process. J Cell Biochem 2003; 88: 400-407
7. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004; 114: 1146-1157
8. Yin H, Blanchard KL. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms. Blood 2000; 95: 111-119
9. Robert MF, Morin S, Beaulieu NA et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003; 33: 61-65
10. Goffin J, Eisenhauer E. DNA methyltransferase inhibitors - state of the art. Ann Oncol 2002; 13: 1699-1716
11. Charache S, Dover G, Smith K, Talbot CC Jr, Moyer M, Boyer S. Treatment of sickle cell anemia with 5-azacytidine, results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Proc Natl Acad Sci USA 1983; 80: 4842-4846
12. Lin X, Asgari K, Putzi MJ et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res 2001; 61: 8611-8616
13. Wenger RH, Kvietikova I, Rolfs A, Camenisch G, Gassmann M. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem 1998; 253: 771-777
14. Escher G, Vogt B, Beck T, Guntern D, Frey BM, Frey FJ. Reduced 11beta-hydroxysteroid dehydrogenase activity in the remaining kidney following nephrectomy. Endocrinology 1998; 139: 1533-1539
15. Frey FJ, Odermatt A, Frey BM. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr Opin Nephrol Hypertens 2004; 13: 451-458
16. Funke-Kaiser H, Thomas A, Bremer J et al. Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites. J Hypertens 2003; 21: 2111-2124
17. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-540
18. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556
19. Luft FC, Fineberg NS, Weinberger MH. The influence of age on renal function and renin and aldosterone responses to sodium-volume expansion and contraction in normotensive and mildly hypertensive humans. Am J Hypertens 1992; 5: 520-528